HomeCEO WorldNetflix VP Sues Over Firing Linked to Ketamine Therapy Discl
CEO World

Netflix VP Sues Over Firing Linked to Ketamine Therapy Disclosure

During a corporate trust-building retreat in January 2026, Kevin Baillie disclosed his use of ketamine therapy to manage clinical depression. Two months after sharing these personal details at the Netflix-owned Eyeline Studios event, the vice president was terminated, prompting a lawsuit alleging disability discrimination and wrongful discharge.

Netflix VP Sues Over Firing Linked to Ketamine Therapy Disclosure

In legal filings, Baillie asserts that Netflix’s internal counsel explicitly identified his therapy as a factor in his dismissal. The company’s subsequent investigation into his conduct highlighted instances of profanity and alcohol consumption, including a specific episode involving a headstand while drinking a Guinness. Baillie contends these accusations are hypocritical, arguing that the studio’s environment was defined by a culture of heavy drinking fostered by leadership.

According to the suit, Eyeline CEO Jeff Shapiro maintained a personal bar within his office and frequently distributed alcohol to staff during professional outings. Baillie is seeking a jury trial to address claims of disability discrimination, wrongful termination, and the denial of severance pay. Neither Netflix nor Eyeline Studios has provided a public statement regarding the allegations.

Comments (0)

Leave a comment

No comments yet. Be the first!